首页> 外文OA文献 >A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

【2h】

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

机译：一项随机的，为期52周的针对治疗的目标试验，比较了初次使用胰岛素的2型糖尿病患者中将地特胰岛素和甘精胰岛素作为降糖药物的附加药物时的情况

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes [J] . J. Rosenstock, M. Davies, P. D. Home, Diabetologia . 2008,第3期

机译：一项随机的，为期52周的针对治疗的目标试验，比较了初次使用胰岛素的2型糖尿病患者中将地特胰岛素和甘精胰岛素作为降糖药物的附加药物时的情况
2. A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes [J] . J. Rosenstock, M. Davies, P. D. Home, Diabetologia: clinical and experimental diabetes and metabolism . 2008,第3期

机译：一项随机的，为期52周的针对治疗的目标试验，比较了初次使用胰岛素的2型糖尿病患者中将地特胰岛素和甘精胰岛素作为降糖药物的附加药物时的情况
3. A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes. [J] . Hermansen K, Davies M, Derezinski T, Diabetes care . 2006,第6期

机译：这项为期26周的随机，平行，以治疗为目标的试验，比较了未使用胰岛素的2型糖尿病患者中将Detemir胰岛素与NPH胰岛素作为口服降糖药的补充疗法。
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. Physiology and pharmacology of diabetes therapies in the cat: Insulin detemir, insulin glargine, exenatide and the incretin effect. [D] . Gilor, Chen. 2010

机译：猫的糖尿病疗法的生理和药理作用：地特胰岛素，甘精胰岛素，艾塞那肽和肠降血糖素作用。
6. A randomised 52-week treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes [O] . J. Rosenstock, M. Davies, P. D. Home, -1

机译：一项随机的为期52周的针对治疗的目标试验比较了初次使用胰岛素的2型糖尿病患者中将地特胰岛素和甘精胰岛素作为降糖药物的补充药物时的情况
7. A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes [O] . Rosenstock, J., Davies, M., Home, P. D., 2008

机译：一项随机的，为期52周的针对治疗的目标试验，比较了初次使用胰岛素的2型糖尿病患者中将地特胰岛素和甘精胰岛素作为降糖药物的附加药物时的情况

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

著录项

引文网络

相似文献

相关主题

期刊订阅